However, we observe a statistically significant increase in DR5 mRNA levels in breast cancer cells treated with ONC201 for 48 hours when compared with a vehicle control (Figure 2D, Supplementary Figure 2C). The gene discussed is TNFRSF10B; the disease is breast carcinoma.